NASDAQ:VNDA

Vanda Pharmaceuticals Inc (VNDA) receives a Buy rating from H.C. Wainwright
Roman Campbell
Vanda Pharmaceuticals Inc’s recent filing unveils that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 ...





